The Intestinal Microbiome and the Leaky Gut As Therapeutic Targets in Alcoholic Liver Disease

Overview

Journal Front Physiol

Date 2012 Oct 23

PMID 23087650

Citations 63

Authors

Phillipp Hartmann

Wei-Chung Chen

Bernd Schnabl

Affiliations

Soon will be listed here.

Abstract

Alcoholic liver disease (ALD) encompasses hepatic steatosis, which may progress to alcoholic hepatitis, fibrosis, and cirrhosis. It remains a leading cause of morbidity and mortality in the US and worldwide. The severity of liver disease correlates with plasma levels of bacterial products in patients, and experimental ALD depends on the level of gut derived bacterial products in rodents. Since intestinal decontamination and deficiency of bacterial product receptors or their downstream signaling molecules protect from alcohol-induced liver disease, bacterial translocation (BT), qualitative, and quantitative changes of the enteric microbiome are considered as being of fundamental importance in the pathogenesis of ALD. Recent enhancements in diagnostic technologies provide a better insight into these shifts. This review highlights vital events in ALD such as BT, the importance of Toll-like receptor (TLR) signaling, intestinal bacterial overgrowth (IBO), and changes in the intestinal microbiome. Furthermore, a treatment trial section of patients reviews possible future options of therapy for ALD modifying the enteric microbiome.

Citing Articles

MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives.

Karin M, Kim J Mol Oncol. 2024; 19(2):275-294.

PMID: 38874196 PMC: 11793012. DOI: 10.1002/1878-0261.13685.

Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.

Bahitham W, Alghamdi S, Omer I, Alsudais A, Hakeem I, Alghamdi A Biomedicines. 2024; 12(3).

PMID: 38540163 PMC: 10967987. DOI: 10.3390/biomedicines12030550.

Alcohol induced NLRP3 inflammasome activation in the brain of rats is attenuated by ATRA supplementation.

Priyanka S, Thushara A, Rauf A, Indira M Brain Behav Immun Health. 2024; 2:100024.

PMID: 38377424 PMC: 8474578. DOI: 10.1016/j.bbih.2019.100024.

Impact of Hypoxia-Hyperoxia Exposures on Cardiometabolic Risk Factors and TMAO Levels in Patients with Metabolic Syndrome.

Bestavashvili A, Glazachev O, Ibragimova S, Suvorov A, Bestavasvili A, Ibraimov S Int J Mol Sci. 2023; 24(19).

PMID: 37833946 PMC: 10572339. DOI: 10.3390/ijms241914498.

Caulerpa lentillifera improves ethanol-induced liver injury and modulates the gut microbiota in rats.

Lin K, Yang H, Yang S, Chen Y, Watanabe Y, Chen J Curr Res Food Sci. 2023; 7:100546.

PMID: 37483276 PMC: 10362798. DOI: 10.1016/j.crfs.2023.100546.

References

Kudo H, Takahara T, Yata Y, Kawai K, Zhang W, Sugiyama T . Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. J Hepatol. 2009; 51(1):168-75. DOI: 10.1016/j.jhep.2009.02.032. View

Inokuchi S, Tsukamoto H, Park E, Liu Z, Brenner D, Seki E . Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin Exp Res. 2011; 35(8):1509-18. PMC: 3131439. DOI: 10.1111/j.1530-0277.2011.01487.x. View

Brandl K, Plitas G, Mihu C, Ubeda C, Jia T, Fleisher M . Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 2008; 455(7214):804-7. PMC: 2663337. DOI: 10.1038/nature07250. View

Chang C, Chen G, Lien H, Yeh H . Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 1998; 28(5):1187-90. DOI: 10.1002/hep.510280504. View

Mutlu E, Keshavarzian A, Engen P, Forsyth C, Sikaroodi M, Gillevet P . Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res. 2009; 33(10):1836-46. PMC: 3684271. DOI: 10.1111/j.1530-0277.2009.01022.x. View

Nagaki M, Sugiyama A, Osawa Y, Naiki T, Nakashima S, Nozawa Y . Lethal hepatic apoptosis mediated by tumor necrosis factor receptor, unlike Fas-mediated apoptosis, requires hepatocyte sensitization in mice. J Hepatol. 1999; 31(6):997-1005. DOI: 10.1016/s0168-8278(99)80311-0. View

Fouts D, Torralba M, Nelson K, Brenner D, Schnabl B . Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J Hepatol. 2012; 56(6):1283-92. PMC: 3357486. DOI: 10.1016/j.jhep.2012.01.019. View

Gao B, Bataller R . Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011; 141(5):1572-85. PMC: 3214974. DOI: 10.1053/j.gastro.2011.09.002. View

Koop D, Klopfenstein B, Iimuro Y, Thurman R . Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1. Mol Pharmacol. 1997; 51(6):944-50. DOI: 10.1124/mol.51.6.944. View

10.

Keshavarzian A, Choudhary S, Holmes E, Yong S, Banan A, Jakate S . Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther. 2001; 299(2):442-8. View

11.

Mandayam S, Jamal M, Morgan T . Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004; 24(3):217-32. DOI: 10.1055/s-2004-832936. View

12.

Inagaki T, Moschetta A, Lee Y, Peng L, Zhao G, Downes M . Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A. 2006; 103(10):3920-5. PMC: 1450165. DOI: 10.1073/pnas.0509592103. View

13.

Madrid A, Cumsille F, Defilippi C . Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci. 1997; 42(4):738-42. DOI: 10.1023/a:1018899611006. View

14.

Metz G, Gassull M, Drasar B, Jenkins D, Blendis L . Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet. 1976; 1(7961):668-9. DOI: 10.1016/s0140-6736(76)92779-3. View

15.

Leber B, Spindelboeck W, Stadlbauer V . Infectious complications of acute and chronic liver disease. Semin Respir Crit Care Med. 2012; 33(1):80-95. DOI: 10.1055/s-0032-1301737. View

16.

Camp J, Kanther M, Semova I, Rawls J . Patterns and scales in gastrointestinal microbial ecology. Gastroenterology. 2009; 136(6):1989-2002. PMC: 4841941. DOI: 10.1053/j.gastro.2009.02.075. View

17.

Runyon B, Squier S, Borzio M . Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol. 1994; 21(5):792-6. DOI: 10.1016/s0168-8278(94)80241-6. View

18.

Wang F, Graham W, Wang Y, Witkowski E, Schwarz B, Turner J . Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol. 2005; 166(2):409-19. PMC: 1237049. DOI: 10.1016/s0002-9440(10)62264-x. View

19.

Purohit V, Bode J, Bode C, Brenner D, Choudhry M, Hamilton F . Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol. 2008; 42(5):349-61. PMC: 2614138. DOI: 10.1016/j.alcohol.2008.03.131. View

20.

Madrid A, Hurtado C, Venegas M, Cumsille F, Defilippi C . Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am J Gastroenterol. 2001; 96(4):1251-5. DOI: 10.1111/j.1572-0241.2001.03636.x. View